| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,314 |
9,596 |
$1.81M |
| 99215 |
Prolong outpt/office vis |
4,151 |
3,853 |
$600K |
| S9083 |
Global fee urgent care centers |
3,949 |
3,670 |
$462K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,113 |
1,987 |
$455K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
15,979 |
11,946 |
$395K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
13,366 |
12,624 |
$276K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
9,559 |
9,161 |
$117K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
631 |
598 |
$105K |
| 71046 |
Radiologic examination, chest; 2 views |
1,137 |
1,098 |
$73K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
757 |
724 |
$68K |
| 99205 |
Prolong outpt/office vis |
285 |
272 |
$49K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
281 |
267 |
$46K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
210 |
199 |
$42K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
959 |
912 |
$41K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
758 |
694 |
$33K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
655 |
622 |
$16K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
433 |
415 |
$11K |
| 94664 |
|
621 |
550 |
$7K |
| 81001 |
|
751 |
716 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
281 |
262 |
$4K |
| 73610 |
|
17 |
17 |
$3K |
| 87581 |
|
479 |
463 |
$995.87 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
761 |
723 |
$507.52 |
| 87807 |
|
81 |
78 |
$19.84 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
106 |
102 |
$9.92 |
| 87486 |
|
435 |
419 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
29 |
25 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
531 |
503 |
$0.00 |
| 29515 |
|
14 |
14 |
$0.00 |